Lawrence Otto Klein Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 12 hours ago
Lawrence Otto Klein has an estimated net worth of at least $93.9 million*, as of Aug. 26, 2026. They own 925,580 shares of ORKA stock. They have sold 78,458 shares of ORKA stock since 2021, for an estimated $191,901.
Lawrence Otto Klein $ORKA SEC Form 4 Insider Trading
Lawrence Otto Klein has filed a total of 5 insider trades in $ORKA since 2021. Their most recent trade was a sale of 6,604 shares, made on Sep 01, 2026. Their largest trade was a sale of 63,596 shares, made on Sep 01, 2026. We estimate that they now own 925,580 shares of $ORKA, worth an estimated $93.7 million.
Insider Trading at $ORKA
There have been a total of 91 insider trades reported at $ORKA since 2021, with 122,882 shares purchased and 4.0 million shares sold. The most active insider traders in $ORKA stock have been Joana Goncalves, Arjun Agarwal, and Laura Lee Sandler. The most recent trade was a sale of 1,000 shares reported by Laura Lee Sandler (Chief Operating Officer), made on Sep 01, 2026.
History of Insider Stock Trades by Lawrence Otto Klein
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ORKA
|
Sale | 6,604 | Sep 01, 2026 | Sept. 1, 2026, 6:35 p.m. |
|
ORKA
|
Sale | 63,596 | Sep 01, 2026 | Sept. 1, 2026, 6:35 p.m. |
|
ORKA
|
Sale | 4,800 | Sep 01, 2026 | Sept. 1, 2026, 6:35 p.m. |
|
ORKA
|
Sale | 1,729 | Jun 15, 2026 | June 15, 2026, 6:52 p.m. |
|
ORKA
|
Sale | 1,729 | Mar 16, 2026 | March 17, 2026, 4:10 p.m. |
$ORKA Executives and Stock Owners with Insider Trades
-
Joana Goncalves, Chief Medical Officer
-
Arjun Agarwal, Senior Vice President, Finance
-
Laura Lee Sandler, Chief Operating Officer
-
Paul T Quinlan, General Counsel
-
Lawrence Otto Klein, Chief Executive Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.